The global non‑specific endonucleases market was valued at USD 353.60 million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 6.15 % between 2025 and 2034, illustrating steady demand for enzyme‑based nucleic acid cleavage tools across biotechnology, diagnostics and academic research. This growth reflects increasing reliance on these enzymes for processes such as...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek